These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6776564)

  • 41. Blocking naloxone-precipitated withdrawal in rats and hamsters.
    Schnur P; Espinoza M; Flores R; Ortiz S; Vallejos S; Wainwright M
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1093-8. PubMed ID: 1475293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of chronic treatment with diazepam, phenobarbital, or amphetamine on naloxone-precipitated morphine withdrawal.
    Eisenberg RM
    Drug Alcohol Depend; 1985 Aug; 15(4):375-81. PubMed ID: 4053975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antinociceptive properties of thyrotropin releasing hormone in mice: comparison with morphine.
    Boschi G; Desiles M; Reny V; Rips R; Wrigglesworth S
    Br J Pharmacol; 1983 May; 79(1):85-92. PubMed ID: 6409194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
    Cappendijk SL; de Vries R; Dzoljic MR
    Eur Neuropsychopharmacol; 1993 Jun; 3(2):111-6. PubMed ID: 8395919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modification of the expression of naloxone-precipitated withdrawal signs in morphine-dependent mice by diabetes: possible involvement of protein kinase C.
    Ohsawa M; Kamei J
    Jpn J Pharmacol; 1999 Mar; 79(3):303-11. PubMed ID: 10230858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice.
    Zarrindast MR; Farzin D
    Eur J Pharmacol; 1996 Feb; 298(1):1-6. PubMed ID: 8867912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
    Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
    Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine.
    Barrios M; Baeyens JM
    Psychopharmacology (Berl); 1991; 104(3):397-403. PubMed ID: 1718013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal.
    McLane VD; Bergquist I; Cormier J; Barlow DJ; Houseknecht KL; Bilsky EJ; Cao L
    Life Sci; 2017 Sep; 185():1-7. PubMed ID: 28723417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
    Azar MR; Jones BC; Schulteis G
    Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Pharmacol Biochem Behav; 2003 Dec; 76(3-4):493-503. PubMed ID: 14643849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opiate dependence following acute injections of morphine and naloxone: the assessment of various withdrawal signs.
    Ritzmann RF
    Pharmacol Biochem Behav; 1981 Apr; 14(4):575-7. PubMed ID: 7195040
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of GABAergic system on naloxone-induced jumping in morphine-dependent mice.
    Zarrindast MR; Mousa-Ahmadi E
    Eur J Pharmacol; 1999 Sep; 381(2-3):129-33. PubMed ID: 10554880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
    Neal BS; Sparber SB
    J Pharmacol Exp Ther; 1986 Jan; 236(1):157-65. PubMed ID: 3001281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of thyrotropin releasing hormone on pentobarbital tolerance.
    Bhargava HN
    Eur J Pharmacol; 1981 Jun; 72(1):63-8. PubMed ID: 6790297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppressive effects by cysteine protease inhibitors on naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Tan-No K; Sato T; Shimoda M; Nakagawasai O; Niijima F; Kawamura S; Furuta S; Sato T; Satoh S; Silberring J; Terenius L; Tadano T
    Neuropeptides; 2010 Jun; 44(3):279-83. PubMed ID: 20189644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of divalent ions on morphine analgesia and abstinence syndrome in morphine-tolerant and -dependent mice.
    Bhargava HN
    Psychopharmacology (Berl); 1978 Apr; 57(2):223-5. PubMed ID: 418458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
    Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
    Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Naloxone-precipitated withdrawal as a function of the morphine-naloxone interval.
    Linseman MA
    Psychopharmacology (Berl); 1977 Oct; 54(2):159-64. PubMed ID: 412210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.